' Baby Tam' Effective, Tolerable for Breast Cancer Prevention'Baby Tam' Effective, Tolerable for Breast Cancer Prevention
Lower-dose tamoxifen aims to reduce those side effects, but there remains some uncertainty about the minimum dose required to maintain efficacy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Tamoxifen Fails to Deliver on Clinical Promise for Duchenne Muscular Dystrophy
(MedPage Today) -- Repurposed tamoxifen failed to delay disease progression as an adjunct to corticosteroids among boys with Duchenne muscular dystrophy (DMD), the phase III TAMDMD trial showed. In an intention-to-treat population, no significant... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - October 10, 2023 Category: Neurology Source Type: news

I thought having cancer was the hard part. Then after came
I remember being surprised the first time I saw it. It was bright white and as small as a tic tac but round instead of oval. My oncologist assured me I'd be thanking her in a few months. As someone who had had painful periods since the first one I ever got, she said: "This medication will make all…#tamoxifen #darceygohring #scarymommy #coronacity (Source: Reuters: Health)
Source: Reuters: Health - August 26, 2023 Category: Consumer Health News Source Type: news

Breast Cancer: Hope in Sight for Improved Tamoxifen Therapy? Breast Cancer: Hope in Sight for Improved Tamoxifen Therapy?
Research suggests that an enzyme could become a biomarker of response to tamoxifen therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 24, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Expands Indication for Use of Abemaciclib With Early, High-Risk Breast Cancer
FRIDAY, March 10, 2023 -- Abemaciclib (Verzenio) with endocrine therapy (tamoxifen or an aromatase inhibitor) is now approved for the adjuvant treatment of adult patients with hormone receptor-positive, human epidermal growth factor receptor... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 10, 2023 Category: Pharmaceuticals Source Type: news

FDA expands early breast cancer indication for abemaciclib with endocrine therapy
On March 3, 2023, the Food and Drug Administration (FDA) approved abemaciclib (Verzenio, Eli Lilly and Company) with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 6, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Mixed Results With Hormonal Strategies for Premenopausal Breast Cancer
(MedPage Today) -- Pairing ovarian function suppression (OFS) with an aromatase inhibitor significantly reduced the risk of premenopausal breast cancer recurrence but did not improve overall survival (OS) versus a tamoxifen strategy, long-term... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 20, 2022 Category: OBGYN Source Type: news

Risk - Reducing Medications Can Cut Breast Cancer Death Rates
Tamoxifen with annual screening reduced invasive breast cancers and breast cancer deaths by 40 and 57 percent, respectively (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 13, 2022 Category: Cancer & Oncology Tags: Gynecology, Internal Medicine, Oncology, Pharmacy, Radiology, Journal, Source Type: news

Tamoxifen Ups Risk of Uterine Disease, Endometrial Cancer Tamoxifen Ups Risk of Uterine Disease, Endometrial Cancer
New research suggests a nearly fourfold increased risk of endometrial cancer among premenopausal women treated with tamoxifen for breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 1, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Risk of Uterine Diseases, Cancers Up With Tamoxifen Treatment
TUESDAY, Nov. 29, 2022 -- Tamoxifen treatment is associated with increased risk of endometrial hyperplasia, polyps, and carcinoma, as well as other uterine cancers, according to a study published online Nov. 28 in JAMA Network Open. Ki-Jin Ryu,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Uterine Cancer: What to Know About Symptoms and Treatment
A new study raised alarms about chemical hair straighteners being linked to the disease, but doctors say there are telltale symptoms to watch for. (Source: NYT Health)
Source: NYT Health - October 25, 2022 Category: Consumer Health News Authors: Dani Blum Tags: Women and Girls Uterus Research Hazardous and Toxic Substances Cancer Black People Gynecology and Gynecologists Estrogen Menopause Tamoxifen (Drug) Source Type: news

2 Years of Endocrine Therapy, 2 Decades of Protection From Metastatic Breast Cancer
(MedPage Today) -- Two years of adjuvant endocrine therapy for premenopausal breast cancer protected against metastatic recurrence for 20 years, a new analysis of a randomized trial showed. Premenopausal women who received goserelin, tamoxifen... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 1, 2022 Category: Hematology Source Type: news

Large Benefit From Ovarian Function Suppression in Breast Cancer Large Benefit From Ovarian Function Suppression in Breast Cancer
Eight-year follow-up of the ASTRRA trial confirms and extends support for adding 2 years of ovarian function suppression with goserelin to tamoxifen, compared with tamoxifen alone.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 23, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Easing Tamoxifen, Aromatase Inhibitors ’ Side Effects for Breast Cancer Treatment
Hormone therapy for breast cancer – such as tamoxifen and aromatase inhibitors – can help prevent the cancer from coming back. If you have side effects, these things may help. (Source: WebMD Health)
Source: WebMD Health - June 21, 2022 Category: Consumer Health News Source Type: news

Twenty Years and Counting: Tamoxifen Benefit in Breast Cancer Twenty Years and Counting: Tamoxifen Benefit in Breast Cancer
New data from a 20-year follow-up of patients with ER-positive/HER2-negative breast cancer identifies those who have lasting benefit from tamoxifen.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 11, 2022 Category: Pathology Tags: Hematology-Oncology News Source Type: news